This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Immunity Pharma Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Avi Ben-shimon: Innovator in Peptide Therapeutics
Introduction
Avi Ben-shimon is a notable inventor based in Ayanot, Israel. He has made significant contributions to the field of peptide compounds, particularly in therapeutic applications. His work focuses on innovative solutions to medical challenges, showcasing his dedication to advancing healthcare.
Latest Patents
Avi Ben-shimon holds a patent for "Peptide compounds and therapeutic uses of same." This patent discloses isolated peptides capable of reducing the amount of dexamethasone-induced spleen and/or thymus weight loss in a mouse. This innovation has potential implications for therapeutic strategies in various medical conditions.
Career Highlights
Avi is associated with Immunity Pharma Ltd., where he applies his expertise in peptide research. His role at the company allows him to collaborate with other professionals in the field, enhancing the development of therapeutic solutions.
Collaborations
Avi Ben-shimon works alongside his coworker, Eran Ovadia, contributing to the innovative environment at Immunity Pharma Ltd. Their collaboration fosters a dynamic approach to research and development in peptide therapeutics.
Conclusion
Avi Ben-shimon's work in peptide compounds exemplifies the intersection of innovation and healthcare. His contributions are paving the way for new therapeutic options, demonstrating the importance of research in improving medical outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile